Enhanced Sarcoplasmic Reticulum Ca <sup>2+</sup> Leak and Increased Na <sup>+</sup> -Ca <sup>2+</sup> Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation

  • Niels Voigt
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...
  • Na Li
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...
  • Qiongling Wang
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...
  • Wei Wang
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...
  • Andrew W. Trafford
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...
  • Issam Abu-Taha
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...
  • Qiang Sun
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...
  • Thomas Wieland
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...
  • Ursula Ravens
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...
  • Stanley Nattel
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...
  • Xander H.T. Wehrens
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...
  • Dobromir Dobrev
    From the Division of Experimental Cardiology (N.V., I.A.-T., Q.S., D.D.) and Department of Experimental and Clinical Pharmacology (T.W.), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany (N.V., U.R., D.D.); Department of Molecular Physiology and Biophysics, Department of Medicine, Baylor College of Medicine, Houston, TX (N.L., Q.W., W.W., X.H.T.W.); Unit of Cardiac Physiology,...

抄録

<jats:sec> <jats:title>Background—</jats:title> <jats:p> Delayed afterdepolarizations (DADs) carried by Na <jats:sup>+</jats:sup> -Ca <jats:sup>2+</jats:sup> -exchange current (I <jats:sub>NCX</jats:sub> ) in response to sarcoplasmic reticulum (SR) Ca <jats:sup>2+</jats:sup> leak can promote atrial fibrillation (AF). The mechanisms leading to delayed afterdepolarizations in AF patients have not been defined. </jats:p> </jats:sec> <jats:sec> <jats:title>Methods and Results—</jats:title> <jats:p> Protein levels (Western blot), membrane currents and action potentials (patch clamp), and [Ca <jats:sup>2+</jats:sup> ] <jats:sub>i</jats:sub> (Fluo-3) were measured in right atrial samples from 76 sinus rhythm (control) and 72 chronic AF (cAF) patients. Diastolic [Ca <jats:sup>2+</jats:sup> ] <jats:sub>i</jats:sub> and SR Ca <jats:sup>2+</jats:sup> content (integrated I <jats:sub>NCX</jats:sub> during caffeine-induced Ca <jats:sup>2+</jats:sup> transient) were unchanged, whereas diastolic SR Ca <jats:sup>2+</jats:sup> leak, estimated by blocking ryanodine receptors (RyR2) with tetracaine, was ≈50% higher in cAF versus control. Single-channel recordings from atrial RyR2 reconstituted into lipid bilayers revealed enhanced open probability in cAF samples, providing a molecular basis for increased SR Ca <jats:sup>2+</jats:sup> leak. Calmodulin expression (60%), Ca <jats:sup>2+</jats:sup> /calmodulin-dependent protein kinase-II (CaMKII) autophosphorylation at Thr287 (87%), and RyR2 phosphorylation at Ser2808 (protein kinase A/CaMKII site, 236%) and Ser2814 (CaMKII site, 77%) were increased in cAF. The selective CaMKII blocker KN-93 decreased SR Ca <jats:sup>2+</jats:sup> leak, the frequency of spontaneous Ca <jats:sup>2+</jats:sup> release events, and RyR2 open probability in cAF, whereas protein kinase A inhibition with H-89 was ineffective. Knock-in mice with constitutively phosphorylated RyR2 at Ser2814 showed a higher incidence of Ca <jats:sup>2+</jats:sup> sparks and increased susceptibility to pacing-induced AF compared with controls. The relationship between [Ca <jats:sup>2+</jats:sup> ] <jats:sub>i</jats:sub> and I <jats:sub>NCX</jats:sub> density revealed I <jats:sub>NCX</jats:sub> upregulation in cAF. Spontaneous Ca <jats:sup>2+</jats:sup> release events accompanied by inward I <jats:sub>NCX</jats:sub> currents and delayed afterdepolarizations/triggered activity occurred more often and the sensitivity of resting membrane voltage to elevated [Ca <jats:sup>2+</jats:sup> ] <jats:sub>i</jats:sub> (diastolic [Ca <jats:sup>2+</jats:sup> ] <jats:sub>i</jats:sub> –voltage coupling gain) was higher in cAF compared with control. </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions—</jats:title> <jats:p> Enhanced SR Ca <jats:sup>2+</jats:sup> leak through CaMKII-hyperphosphorylated RyR2, in combination with larger I <jats:sub>NCX</jats:sub> for a given SR Ca <jats:sup>2+</jats:sup> release and increased diastolic [Ca <jats:sup>2+</jats:sup> ] <jats:sub>i</jats:sub> -voltage coupling gain, causes AF-promoting atrial delayed afterdepolarizations/triggered activity in cAF patients. </jats:p> </jats:sec>

収録刊行物

  • Circulation

    Circulation 125 (17), 2059-2070, 2012-05

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (11)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ